WallStreetZenWallStreetZen

NASDAQ: PRTA
Prothena Corp Public Ltd Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRTA past revenue growth

How has PRTA's revenue growth performed historically?
Company
69.5%
Industry
145.73%
Market
17.2%
PRTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRTA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRTA earnings and revenue history

Current Revenue
$91.4M
Current Earnings
-$147.0M
Current Profit Margin
-160.9%

PRTA Return on Equity

Current Company
-24.8%
Current Industry
-63.5%
Current Market
188%
PRTA's Return on Equity (-24.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRTA announces earnings.

PRTA Return on Assets

Current Company
-20.2%
Current Industry
2.9%
PRTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRTA Return on Capital Employed

Current Company
-25.09%
Current Industry
19.5%
PRTA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRTA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRTA$91.37M-$152.07M-$147.03M+148.98%N/A
TARS$17.45M-$131.13M-$135.89M-44.69%N/A
BLTE$0.00-$31.20M-$31.63MN/AN/A
SRRK$0.00-$155.82M-$165.79M-100.00%N/A
AUTL$1.70M-$152.71M-$208.38M+2.90%N/A
View Top Biotech Stocks

PRTA earnings dates

Next earnings date
Apr 29, 2024

Prothena Public Co Earnings & Revenue FAQ

What were PRTA's earnings last quarter?

On Invalid Date, Prothena Public Co (NASDAQ: PRTA) reported Q4 2023 earnings per share (EPS) of -$1.26, up 887.5% year over year. Total Prothena Public Co earnings for the quarter were -$67.48 million. In the same quarter last year, Prothena Public Co's earnings per share (EPS) was $0.16.

If you're new to stock investing, here's how to buy Prothena Public Co stock.

What was PRTA's earnings growth in the past year?

As of Q2 2024, Prothena Public Co's earnings has grown year over year. Prothena Public Co's earnings in the past year totalled -$147.03 million.

What is PRTA's earnings date?

Prothena Public Co's earnings date is Invalid Date. Add PRTA to your watchlist to be reminded of PRTA's next earnings announcement.

What was PRTA's revenue last quarter?

On Invalid Date, Prothena Public Co (NASDAQ: PRTA) reported Q4 2023 revenue of $316.00 thousand up 99.37% year over year. In the same quarter last year, Prothena Public Co's revenue was $49.92 million.

What was PRTA's revenue growth in the past year?

As of Q2 2024, Prothena Public Co's revenue has grown 69.5% year over year. This is 76.23 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Prothena Public Co's revenue in the past year totalled $91.37 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.